Searched for
OXFORD VACCINE GROUP
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- AZ booster raises antibody levels against Omicron, says firmIt said that the increased response was observed in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, adding ...
- AstraZeneca says US trial data shows vaccine 79% effectiveThe U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announed...
- AstraZeneca vaccine's promise now drawn into questionIn the latest, around a dozen countries have suspended its use as a precaution after blood clots suffered by some of those vaccinated.
- Oxford University to test COVID-19 vaccine response among children for first timeThe new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed sta...
- Does the world need new COVID vaccines? 'Jury is out', says Oxford's Pollard"I think the jury is out on that at the moment, but all developers are preparing new vaccines so if we do need them, we'll have them availa...
- AstraZeneca vaccine less effective against S.African strain: studyThe University of Witwatersrand, Johannesburg, which conducted the trial, said in a statement that the vaccine "provides minimal protection...
- AstraZeneca, Oxford expect 'next generation' COVID-19 vaccine to tackle variants by autumn - executiveAsked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said "as ra...
- 'So pleased' - Britain gives first dose of Oxford/AstraZeneca vaccine to dialysis patientPinker, a retired maintenance manager, paid tribute to the scientists who had developed the shot, saying he was looking forward to celebrat...
- 3 Covid vaccines’ efficacy higher than flu shotsAnthony Fauci, top infectious disease expert in the US, had said the over 90% efficacy of Pfizer vaccine candidate ‘is just extraordinary’ ...
- Evidence of coronavirus vaccines working in a 'half-measure' takes experts by surpriseSarah Gilbert, professor at Oxford's Nuffield Department of Medicine, said the better result with a smaller initial dose could be because t...
- Some signs AstraZeneca vaccine durability could be a year: Chief investigator"We don't know yet if this virus will be mutating away from the immune response," the Oxford vaccine group's director Andrew Pollard told r...
- Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virusSpeaking in a briefing, Andrew Pollard, director of the Oxford Vaccine Group, said it is hard to explain the different efficacy rates betwe...
- Oxford's COVID-19 vaccine trial results 'definitely' before Christmas - investigatorAsked if it was too early to say whether the vaccine, which is licensed to AstraZeneca, stops disease developing, Andrew Pollard, director ...
- AstraZeneca COVID-19 shot candidate shows promise among elderly in trialsThe data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70 - wh...
- Oxford University Covid-19 vaccine ‘encouraging' for older age groupsThe findings published in ‘Lancet' on Thursday based on 560 healthy adult volunteers shows that the ChAdOx1 nCoV-19 vaccine is “safe and we...
- AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite pause in trialsEarlier this week, the UK-Swedish company reportedly froze the trials after discovering that one participant was sick with transverse myeli...
- AstraZeneca's COVID-19 vaccine reaches phase 3 clinical trials in US, says TrumpAstraZeneca is one of the leaders in the race to develop COVID-19 vaccine. Other companies that have COVID-19 vaccines in phase 3 trials in...
- Government lab starts testing Oxford’s vaccine candidate to determine its sterilityThe Central Drugs Laboratory in Kasauli, Himachal Pradesh, is testing the first batch of the vaccine candidate to determine its sterility —...
Load More
